Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

DSpace Repository

Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry

Author: Serna-Higuita, Lina Maria; Amaral, Teresa; Forschner, Andrea; Leiter, Ulrike; Flatz, Lukas; Seeber, Olivia; Thomas, Ioannis; Garbe, Claus; Eigentler, Thomas Kurt; Martus, Peter
Tübinger Autor(en):
Amaral, Teresa
Flatz, Lukas
Thomas, Ioannis
Garbe, Claus
Eigentler, Thomas Kurt
Martus, Peter
Serna Higuita, Lina María
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Seeber, Tonia Olivia
Published in: Cancers (2021), Bd. 13 (23), Article 6141
Verlagsangabe: Basel
Language: English
Full text: http://dx.doi.org/10.3390/cancers13236141
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)